• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Technology·5619.T
Share

MRSO Inc. Stocks

¥ 851Last Updated 20.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

¥ 18.46M

¥ 851
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

MRSO, Inc. provides a robust platform for managing appointments for a variety of medical check-ups and health screenings. Its offerings primarily consist of the Health Care Platform (HCPF), DX services, and solutions for large-scale vaccination efforts. The HCPF enables individuals to book medical examinations online through its dedicated MRSO.jp portal. The DX service, on the other hand, implements a web-based reservation system (MRS) for health check-ups and examinations, which seamlessly integrates with healthcare providers' own websites. Furthermore, the company facilitates online scheduling for widespread new coronavirus vaccination programs. Established on February 6, 2015, by founder Tsunegoro Nishino, MRSO, Inc. is based in Tokyo, Japan.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 08:00

JPMorgan has issued its first long-term forecast for Bitcoin. It could outperform stocks and gold

21.10.2026 07:00

Boeing has secured approval for the largest aircraft in the 737 Max family. Why is this important?

21.10.2026 04:37

AI stocks surged: one of the largest server suppliers eased market concerns

21.10.2026 03:02

SpaceX and Tesla Are Discussing a Merger — Musk

21.10.2026 01:11

SpaceX's profit more than doubled expectations. The annual revenue target is $1 trillion.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026